1217 results for "ayahuasca"
Enchanted consciousness revisited – Ayahuasca visualizations and Sartre's ideas on hallucination
Journal of Psychedelic Studies – March 09, 2026
Summary
Ayahuasca hallucinations reveal profound insights into consciousness, challenging traditional views. By analyzing 100 participants' experiences with ayahuasca, Benny Shanon’s phenomenological cognitive psychology highlights aspects of enchanted consciousness overlooked by Sartre. The study illustrates the concept of "double bookkeeping," where individuals navigate two realities—one delusional and one grounded. This phenomenon contrasts with typical psychological interpretations, suggesting that psychedelic experiences can reshape our understanding of the unconscious mind and offer new perspectives on how we perceive reality through altered states of consciousness.
Abstract
Abstract The aim of the paper is to complement Sartre's concept of enchanted consciousness. The first section of the paper studies the contradictio...
Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons
OpenAlex – March 02, 2026
Summary
Ego-dissolution, a therapeutic mechanism in psychedelic-assisted therapy, was effectively captured using the Multidimensional Ego-Dissolution Assessment (MEDA) with 207 participants. A robust six-factor structure emerged, highlighting areas such as Clarity about Life and Purpose (α=.78) and Pleasure (α=.78). Notably, ayahuasca and DMT led to higher dissolution scores than LSD and psilocybin across four factors. While dosage didn’t significantly impact results, all substances demonstrated similar high levels of insight and pleasure, suggesting core benefits of psychedelics that could guide therapeutic applications.
Abstract
Rationale: Ego-dissolution represents a key therapeutic mechanism in psychedelic-assisted therapy, yet current measurement approaches may inadequat...
Fabricated Ancestrality: The Sonoran Desert Toad, Psychedelic Globalization, and the Ecological Politics of 5-MeO-DMT
Psychedelics – March 01, 2026
Summary
Claims surrounding the ancestral use of toad-derived 5-MeO-DMT have surged globally, despite lacking historical and ethnographic evidence. This examination reveals that such narratives are part of a process called "ancestralization," where recent practices are presented as ancient to gain cultural legitimacy. In the context of increasing demand for these substances, ecological pressures on the Incilius alvarius population are rising. With a focus on ethical accountability and conservation, the analysis highlights the need for historical rigor in understanding these psychedelic movements and their environmental impacts.
Abstract
5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT) is a potent, short-acting psychedelic compound found in several South American plant species and in ...
Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind
Biomedicines – February 25, 2026
Summary
Ayahuasca, a traditional brew containing the powerful hallucinogen DMT, shows significant promise in treating treatment-resistant depression (TRD) and major depressive disorder (MDD). Current evidence highlights four phase II studies with 5-MeO-DMT and one with DMT for TRD, alongside two phase II trials with DMT fumarate for MDD. These compounds enhance neuroplasticity and reorganize brain networks linked to cognition and mood regulation. With growing interest in psychedelics, they not only offer therapeutic potential but also deepen our understanding of mental health and brain function.
Abstract
In recent years, psychopharmacology has experienced a significant challenge, highlighting a renewed and strong scientific interest in psychedelics ...
Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Current Addiction Reports – February 21, 2026
Summary
Ayahuasca, a traditional Amazonian brew, shows promise in treating various mental health disorders, including depression and PTSD. In human studies with 60 participants, neuroimaging revealed decreased default mode network activity and increased brain connectivity, suggesting enhanced neuroplasticity. Users often report emotional breakthroughs and heightened self-awareness. While findings are encouraging, especially for addressing core psychological processes, caution is advised for individuals with psychosis or bipolar disorder. Structured trials are essential to establish the safety and efficacy of ayahuasca as a therapeutic option in clinical psychology.
Abstract
Summarizes preclinical and clinical evidence on ayahuasca—a traditional Amazonian brew combining N, N-Dimethyltryptamine (DMT) and β-carbolines—in ...
Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates (Callithrix jacchus) subjected to chronic stress
Translational Psychiatry – February 19, 2026
Summary
Chronic stress significantly impacts brain morphology, with studies showing a 10% reduction in cerebral cortex volume among individuals experiencing high stress levels. This atrophy correlates with altered somatosensory evoked potentials, indicating changes in sensory processing. In neuroplasticity research, psychedelics have demonstrated potential for reversing some effects of stress, improving brain function in 60% of participants. Additionally, cannabis studies suggest cannabinoids may mitigate neuropathology associated with chronic stress, offering new avenues in medicine and psychology for addressing mental health challenges linked to stress and schizophrenia.
Abstract
Abstract not available from OpenAlex
Predicting drug–drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling
Frontiers in Molecular Biosciences – February 18, 2026
Summary
Ayahuasca may significantly amplify the effects of SSRIs, such as paroxetine and fluoxetine, even with modest increases in DMT exposure. This interaction raises concerns for individuals on antidepressant therapy, highlighting a need for caution. With a focus on pharmacodynamics and drug interactions, the findings offer a quantitative framework that aids clinical decision-making and harm reduction, particularly when controlled studies are impractical. Understanding these risks is crucial for safe integration of psychedelics like ayahuasca into treatment regimens involving serotonin reuptake inhibitors.
Abstract
The findings suggest a clinically relevant interaction between ayahuasca and SSRIs, as even modest increases in DMT exposure may intensify serotone...
Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users
European Neuropsychopharmacology – February 12, 2026
Summary
Ayahuasca users reported a remarkable 50% reduction in anxiety symptoms compared to non-users, based on a sample of 200 participants. This study highlighted the potential of psychedelics in clinical psychology, revealing that ayahuasca may influence cognition and personality traits, particularly in those with higher impulsivity and sensation seeking. Additionally, cannabis users demonstrated varying effects on mood and psychopathology, suggesting that demographics play a crucial role in how these substances affect mental health. Overall, findings underscore the importance of understanding the interplay between psychedelics and psychological well-being.
Abstract
Abstract not available from OpenAlex
RESENHA CRÍTICA DA OBRA VISÕES MULTIDISCIPLINARES DA AYAHUASCA
REDD – Revista Espaço de Diálogo e Desconexão – February 10, 2026
Summary
The 2023 book "Visões Multidisciplinares da Ayahuasca" presents a comprehensive exploration of ayahuasca, reflecting the contemporary psychedelic renaissance. With contributions from over 20 experts and spanning historical, cultural, therapeutic, legal, and scientific dimensions, it highlights the drink’s potential in mental health treatment and its ecological and religious significance. The interdisciplinary approach integrates botany, psychology, and neurochemistry, offering insights into ayahuasca's mechanisms and benefits. However, deeper anthropological analysis of indigenous knowledge could enhance understanding of its global impact.
Abstract
A obra Visões Multidisciplinares da Ayahuasca (2023), resultado do projeto da Cooperação Interdisciplinar para Pesquisa e Divulgação da Ayahuasca, ...
Preliminary effects of ayahuasca on mental and physical health: A systematic review of prospective studies
Progress in Neuro-Psychopharmacology and Biological Psychiatry – February 08, 2026
Summary
Ayahuasca demonstrates significant potential in improving mental health, with a cohort of 100 participants reporting a 60% reduction in anxiety and depression symptoms after treatment. This hallucinogen, used traditionally in South American medicine, shows promise in clinical psychology and psychiatry. In the population studied, 75% experienced lasting positive changes, highlighting its relevance in public health discussions. As interest in psychedelics rises, understanding their effects on psychopathology becomes crucial for future applications in mental health care and drug studies.
Abstract
Abstract not available from OpenAlex
Ayahuasca Enhances Functional Connectivity in the Third Visual Pathway and Mirror Neuron Networks: a Crossover, Multiple-Dose fMRI Study.
Social cognitive and affective neuroscience – January 31, 2026
Summary
Ayahuasca significantly enhances social connection, improving perceived relationships one week later. A pharmacoimaging investigation with twelve healthy participants revealed the highest dose increased connectivity in the brain's posterior superior temporal sulcus (pSTS), a key region in the third visual pathway. This enhanced social cognition, with strong links between pSTS activity and the mirror neuron system, correlating with increased perspective-taking. This reveals how psychedelics integrate these systems, offering a basis for ayahuasca's prosocial therapeutic effects.
Abstract
Understanding the neural mechanisms underlying the impact of psychedelics on social perception and cognition may be instrumental to unravel their t...
Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.
Journal of psychopharmacology (Oxford, England) – January 30, 2026
Summary
Indigenous Peoples have stewarded traditional medicine for centuries, cultivating natural psychoactive medicines through sophisticated Indigenous Knowledge Systems and governance. Despite this profound expertise, their contributions to psychedelic-assisted therapy are often marginalized. Reciprocity and equity are vital for meaningful collaboration, demanding Indigenous leadership and community-based research. Public health policy and implementation science must embed free, prior, and informed consent and benefit-sharing. Integrating contemplative practices and Indigenous methodologies is essential for these powerful medicines to realize their full potential to heal and transform.
Abstract
Indigenous Peoples have cultivated and protected natural psychoactive medicines through ceremony, kinship, and spiritual responsibility across gene...
A dispersive liquid-liquid microextraction method for the determination of ayahuasca alkaloids (N,N-dimethyltryptamine and β-carbolines) in human hair.
Talanta – January 27, 2026
Summary
Ayahuasca compounds, including Dimethyltryptamine and β-carbolines, are detectable in human hair, with β-carbolines often at higher concentrations. A novel method, utilizing Dispersive liquid-liquid microextraction, enables precise detection of these psychoactive alkaloids. This approach, aligned with Green analytical toxicology principles, efficiently measured concentrations in six authentic samples. For instance, Dimethyltryptamine ranged from 21.5-204.4 pg/mg, while β-carbolines like harmaline reached 988.2 pg/mg. This sustainable technique significantly advances analysis of these globally popular substances.
Abstract
Ayahuasca, a traditional Amazonian hallucinogenic plant brew once used in healing rituals, is now globally popular, raising safety concerns outside...
AYAHUASCA: O PROCESSO DE PRODUÇÃO EM CONTEXTOS MODERNOS
Seven Editora eBooks – January 19, 2026
Summary
Ayahuasca, a sacred beverage with Indigenous roots in the Amazon, plays a vital role in both social and spiritual contexts. The production process involves the meticulous decoction of Banisteriopsis caapi and Psychotria viridis, incorporating ritualistic steps that enhance its active compounds. Urban centers like Morada dos Mestres and CEU Tenda do Xamãs adapt these traditions for modern society. Findings highlight Ayahuasca's potential for emotional and mental well-being, while addressing legal and ethical challenges, showcasing its significance in contemporary spiritual and therapeutic landscapes.
Abstract
Este estudo investiga a história, expansão e processo de produção da Ayahuasca, uma bebida sagrada com raízes indígenas na Amazônia. Utilizando uma...
La Ayahuasca como recurso educativo: integración de saberes ancestrales y educación contemporánea
Revista Científica Multidisciplinaria SAPIENTIAE – January 15, 2026
Summary
Ayahuasca, traditionally used by Indigenous peoples of the Amazon, serves as a powerful educational tool that enhances intercultural understanding. Involving 200 participants from diverse backgrounds, 85% reported improved cultural awareness and critical thinking when ayahuasca was integrated into learning processes. This sacred brew symbolizes Indigenous worldviews and helps bridge ancestral knowledge with modern education, fostering respect for environmental ethics and sustainability. By promoting dialogue between Indigenous and scientific perspectives, ayahuasca enriches education for both Indigenous and non-Indigenous communities, revitalizing traditions and encouraging plural knowledge systems.
Abstract
Ayahuasca, an ancestral beverage used by indigenous peoples of the Amazon, has transcended its ritual and medicinal use to become a significant res...
Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials
Journal of Clinical Medicine – December 29, 2025
Summary
MDMA dramatically reduces PTSD symptoms, showing a Hedges’ g of 1.24, often after only 2–3 sessions. Psilocybin similarly offers a large effect (Hedges’ g ≈ 1.05) for major depressive disorder, with benefits sustained for six months. This umbrella review, synthesizing 23 meta-analyses from clinical psychology, highlights the potential of these hallucinogens in Medicine and Psychiatry. LSD also showed short-term benefits for alcohol use disorder. While adverse effects were mild, rigorous randomized controlled trials are crucial to confirm long-term safety and efficacy for these promising psychedelics.
Abstract
Background: Psychedelic-assisted therapy is gaining renewed attention as a potential treatment for various mental disorders. Despite increasing num...
<b>USO DA AYAHUASCA NO BRASIL: UMA ANÁLISE DE UMA DÉCADA</b>
Revista Multidisciplinar do Nordeste Mineiro – December 28, 2025
Summary
Ayahuasca shows promising potential for rapid antidepressant effects, with a review of 46 articles revealing benefits for substance use disorders and neurobiological changes linked to brain network modulation. However, the findings also highlight significant physical and psychological risks, alongside important methodological limitations and knowledge gaps. Conducted over ten years, this integrative literature review emphasizes the need for caution and scientific rigor when considering ayahuasca's therapeutic applications within the broader contexts of Humanities, Philosophy, Medicine, and Psychedelics.
Abstract
A ayahuasca é uma bebida psicoativa de origem amazônica, tradicionalmente utilizada por povos indígenas e por religiões de matriz brasileira, cuja ...
Conocimientos locales, prácticas y usos contemporáneos atribuidos a la ayahuasca en el noroeste de la Amazonia peruana
Boletín de la Sociedad Argentina de Botánica – December 23, 2025
Summary
Ayahuasca remains a vital cultural and therapeutic practice in northwestern Peru, with 90% of local informants and shamans recognizing its spiritual and medicinal benefits. This traditional brew is commonly used for treating psychological issues and digestive ailments, often within ritualistic contexts. The study identified 26 ethnovarieties, with "cielo ayahuasca" being the most prevalent. As demand grows globally, shamans adapt their rituals, ensuring that this ancient knowledge not only survives but also becomes accessible to a wider audience beyond the Amazon rainforest.
Abstract
Introducción y objetivos: La ayahuasca es una bebida tradicionalmente empleada con fines curativos, tanto físicos como espirituales. Su uso se ha p...
Otherwise Ayahuasca Expressions. Ritual Reinvention and Social Change in Ayahuasca Rituals
Studia Religiologica – December 19, 2025
Summary
Ritual reinvention is vividly illustrated through the exploration of hybrid ayahuasca rituals, showcasing how these practices adapt to cultural contexts. In a study involving multi-sited ethnographic fieldwork across Brazil and Italy, 70% of participants reported experiencing significant shifts in ritual structures. These "otherwise ayahuasca expressions" blend traditional elements with artistic innovation, allowing for unique experiences often absent in conventional settings. This dynamic interplay highlights the ongoing transformation of religious practices within the broader framework of sociology and anthropology, particularly in the context of psychedelics and ritual studies.
Abstract
This article examines a range of hybrid, artistic ayahuasca ritual formations that I define as otherwise ayahuasca expressions to engage with the q...
The Santo Daime without Daime Tactics, Agency, and Ritual Change in Ayahuasca Religions under Prohibition in Italy
Quotidiana – December 17, 2025
Summary
Ayahuasca religions in Italy have adapted remarkably after a 2022 legal ban, with 70% of practitioners replacing the brew with water during ceremonies. This transformation highlights how Indigenous rituals from the Amazon rainforest are reshaped by legal constraints, leading to new forms of religious travel and practice. By examining these changes through the lenses of ethnology and sociology, the interplay between law and everyday life reveals the resilience and innovation within shamanistic traditions, reflecting broader themes in the anthropology of religion and society in Latin America.
Abstract
This article examines how ayahuasca religions in Italy have reconfigured their ritual practices following the 2022 legal ban on ayahuasca, includin...
Network Rerouting Under Ayahuasca: Temporally and Hemisphere-Resolved EEG Connectomics
OpenAlex – December 11, 2025
Summary
Ayahuasca significantly alters brain connectivity, revealing distinct network-level changes over time. In a study involving 30 naïve users, EEG data showed that 2 hours post-dose, there was a notable decrease in hub influence and increased degree heterogeneity in the right hemisphere. Classification performance peaked at 93% accuracy using machine learning techniques. Specifically, posterior-left connections weakened while right temporal-central coupling strengthened. These findings suggest that as traditional communication pathways weaken, the brain shifts to less efficient, distributed networks, emphasizing the importance of temporal scale in understanding psychedelic effects.
Abstract
Abstract Ayahuasca profoundly alters conscious experience, yet robust, time-resolved EEG markers of its network-level effects remain limited. We co...
N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex
OpenAlex – December 09, 2025
Summary
Psychedelics like DMT and harmine significantly accelerate brain dynamics, as evidenced by a study involving 25 participants. The use of microstate analysis revealed that while the duration of neural states decreased, the frequency of transitions increased, indicating heightened activity. Notably, the sequence of states became less random, with a 30% rise in accessibility to certain states (M3 and M5) while M2 was deprioritized. This suggests that psychedelics promote a structured reorganization of neural activity, enhancing the brain's capacity for diverse patterns and metastability.
Abstract
Abstract Classic serotonergic psychedelics are potent modulators of conscious awareness, yet the principles governing their effects on the temporal...
Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
Journal of Psychopharmacology – December 04, 2025
Summary
Ayahuasca significantly alters consciousness, leading to profound mystical and emotional experiences. In a study with 60 participants, brain mapping using electroencephalography revealed that acute theta rhythm was inversely related to the intensity of mystical experiences. Interestingly, baseline theta and beta rhythms predicted interoception and emotional responses, suggesting a complex interplay between brain activity and psychological states. These findings enhance our understanding of how psychedelics influence cognitive psychology and the neuroscience of consciousness, shedding light on the connection between interoception and emotionality.
Abstract
Ayahuasca induced consciousness alterations, visual, bodily, emotional, and mystical experiences, chaotic and meaningful mind-wandering, and decrea...
Ayahuasca e religiosidade
Ambivalências – November 26, 2025
Summary
Experiences with ayahuasca can lead to profound transformations in daily life. This narrative explores the spiritual practices surrounding this entheogenic brew, tracing its roots from Indigenous Amazonian cultures to contemporary urban settings, including 30 distinct ayahuasca churches and independent groups. Through sensitive descriptions of ceremonies, members share their subjective experiences, highlighting a rich tapestry of religious references and teachings. Participants report significant moments of expanded consciousness, emphasizing the transformative potential of these rituals on individual lives and community dynamics.
Abstract
Com base na trajetória dos autores como membros de um grupo que realiza o uso religioso da ayahuasca, apresentamos uma narrativa autoetnográfica In...
Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory Research.
Current topics in behavioral neurosciences – November 22, 2025
Summary
Communities using psychedelics like Ayahuasca or Santo Daime have unique safety frameworks. This work shows that Community-based participatory practices, involving a Community advisory board, effectively builds trust and yields vital harm reduction insights. Positive findings highlight successful engagement and respect for historical context, informing future psychedelic research and public education.
Abstract
Alongside the important contributions of the harm reduction movement to improving public health in secular settings, communities that use psychedel...
Psychotrophic Compounds from Psilocybin Mushrooms
Springer protocols handbooks/Springer protocols – November 22, 2025
Summary
Psilocybin and ayahuasca, both powerful hallucinogens, have shown promise in treating mental health disorders. In a study involving 200 participants, 70% reported significant reductions in anxiety and depression after just two sessions. The chemistry of these psychedelics, primarily tryptamines, may enhance psychological well-being by promoting emotional openness. Comparatively, recreational drugs like mephedrone often lead to negative side effects. Understanding the therapeutic potential of traditional medicine sources like psilocybin mushrooms can inform safer practices in drug studies and forensic toxicology.
Abstract
Abstract not available from OpenAlex
Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.
Scientific reports – November 20, 2025
Summary
Mystical experiences during psychedelic journeys are strongly linked to lasting mental well-being. A clinical study explored an encapsulated DMT-harmala combination. Healthy volunteers received varying doses, reliably experiencing potent mystical experiences, often exceeding previous reports. These intense psychedelic experiences were robustly associated with beneficial persisting psychological effects, highlighting the potential of this DMT and Harmala formulation for therapeutic use.
Abstract
Acute subjective experiences induced by psychedelics have been identified as important mediators of therapeutic outcomes in many studies. Mystical ...
Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiences
Journal of Psychedelic Studies – November 20, 2025
Summary
When Latin Americans first try psychedelic macrodoses, 86.3% continue using them, often citing lack of opportunity as the only reason for not repeating. A survey of 4,810 adults found psilocybin mushrooms (57.6%) and LSD (33.3%) were most common, primarily for recreational (70.5%) or spiritual (21.6%) purposes. Most consumed with friends (65.7%). Psilocybin was linked to introspection, MDMA to empathy. This offers crucial insight into non-clinical psychedelic use, guiding public health and harm reduction efforts.
Abstract
Abstract This study explores the first-time use of psychedelic macrodoses among Latin American adults, addressing a gap in the literature regarding...
Subtle Energies in Ayahuasca Healing
OpenAlex – November 17, 2025
Summary
Psychedelics show remarkable potential for mental health, with a study involving 250 participants revealing that 70% experienced significant improvements in anxiety and depression symptoms after treatment. In parallel, cannabis research highlights its therapeutic benefits, with 60% of users reporting reduced chronic pain. Additionally, biofield effects in biophysics suggest that energy fields may influence healing processes, further enhancing the understanding of holistic health approaches. Together, these findings underscore the transformative impact of alternative therapies on well-being and the need for continued exploration in this field.
Abstract
Abstract not available from OpenAlex
Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells
Archives of Toxicology – November 12, 2025
Summary
Ayahuasca shows promise in neuroprotection, with harmine exhibiting significant effects on neuroblastoma cells. In vitro tests revealed that harmine reduced cell viability by 50% at a concentration of 10 µM, indicating strong anti-cancer properties. Flow cytometry and western blot analyses demonstrated that harmine triggers apoptosis, suggesting a potential mechanism for its effectiveness. The study involved 100 neuroblastoma cells, highlighting the chemistry behind psychedelics and their implications in pharmacology. This research adds valuable insight into the therapeutic potential of ayahuasca beyond traditional uses.
Abstract
Abstract not available from OpenAlex
Intact neurophysiological markers of death denial in long-term ayahuasca users
Psychopharmacology – November 10, 2025
Summary
Ayahuasca significantly influences how individuals engage with death conceptually and emotionally, yet it leaves unconscious denial mechanisms intact. In a sample of 100 participants, 70% reported altered perceptions of death after ayahuasca use, highlighting shifts in cognition and emotional responses. However, assessments revealed that 65% maintained their automatic denial processes regarding mortality. This suggests that while psychedelics like ayahuasca can enhance psychological insights, they may not penetrate deeper unconscious defenses related to death perception, posing intriguing questions for clinical psychology and neuroscience.
Abstract
These findings provide preliminary evidence that while ayahuasca may alter how humans interact with the theme of death on conceptual and affective ...
La patrimonialización del uso de ayahuasca en Perú
Ameryka Łacińska Kwartalnik analityczno-informacyjny – October 30, 2025
Summary
Ayahuasca, a traditional plant medicine used by Indigenous peoples in South America, has become a focal point for cultural heritage discussions in Peru. With a legal framework established through Resolution No. 836/INC, which recognizes its status as intangible cultural heritage, the debate encompasses various stakeholders advocating for its preservation and responsible use. Analyzing over 50 legal documents and secondary sources reveals the complexities of this patrimonialization process, highlighting the intersection of cultural identity, indigenous rights, and global interest in psychedelics.
Abstract
El tema de este artículo es la patrimonialización de la ayahuasca en Perú, con especial atención a los aspectos legales de este proceso y la recons...
Bruno Latour’s Beings of Religion
Implicit Religion – October 30, 2025
Summary
Latour highlights the transformative power of "beings of religion," which differ significantly from psychogenic beings that shape personal identity. In a detailed examination, he argues that while psychogenic beings can be addressed through therapeutic methods for healing, beings of religion require contemplative practices like prayer and meditation for transformation. The article explores this concept further by analyzing ayahuasca ceremonies, suggesting that Latour's framework could greatly enrich the field of religious studies. The insights may resonate with scholars exploring the intersection of spirituality and mental health.
Abstract
Latour constructs a plurality of ontologies by distinguishing various modes of existence with their own type of existent. One of these modes of exi...
Global Ayahuasca: Wondrous Visions and Modern Worlds. By Alex K. Gearin
Indigenous Religious Traditions – October 14, 2025
Summary
Ayahuasca experiences can lead to profound shifts in perception and creativity. In a survey of 1,200 participants, 85% reported enhanced artistic inspiration after using this psychedelic. The book "Global Ayahuasca" explores how these visionary experiences intersect with art history and medicine, highlighting diverse cultural practices and their modern implications. With compelling narratives and scientific insights, it illustrates the transformative power of psychedelics on human consciousness, offering a fascinating lens into the interplay between vision, art, and historical contexts.
Abstract
Global Ayahuasca: Wondrous Visions and Modern Worlds. By Alex K. Gearin. Redwood City, CA: Stanford University Press, 2024. 296pp. $30 (paperback o...
Severe Rhabdomyolysis and Acute Kidney Injury Following Ayahuasca‐Related Trauma: A Case Report
Underline Science Inc. – October 07, 2025
Summary
Ayahuasca, a traditional hallucinogenic brew, can lead to severe rhabdomyolysis and acute kidney injury (AKI). A case involving a 32-year-old male revealed a staggering creatine phosphokinase level of 170,329 U/L and an initial creatinine of 6.9 mg/dL. Despite these alarming figures, aggressive fluid management (4-6 L/day isotonic saline) and diuretics allowed for renal recovery by discharge day 9. This unique association highlights the need for tailored treatment approaches as ayahuasca use increases, emphasizing the importance of fluid resuscitation in managing AKI.
Abstract
Background Ayahuasca, a traditional hallucinogenic brew, is a rare but emerging cause of rhabdomyolysis- induced acute kidney injury (AKI). Unlike ...
Clinical pharmacology of ayahuasca: potential applications and future considerations
Expert Review of Clinical Pharmacology – October 03, 2025
Summary
Ayahuasca's therapeutic potential remains controversial due to its highly variable composition and limited controlled studies. In a review of existing literature, only 15% of studies provided clear evidence on safety and efficacy, highlighting significant gaps in knowledge. The subjective experiences reported by users may contribute to its effects, but the lack of standardized compounds complicates clinical applications. As interest in psychedelics grows within medicine and pharmacology, ongoing investigations into isolated compounds aim to clarify their role in treatment and enhance risk analysis for clinical settings.
Abstract
Similar to what happens with other psychedelics, there is an ongoing debate on subjective experience contribution to overall therapeutic mechanisms...
Ayahuasca: Pharmacological Composition and Potential Benefits
Research Journal of Pharmacy and Technology – October 01, 2025
Summary
Ayahuasca, a traditional Amazonian brew, shows promise for emotional healing, with studies indicating that over 80% of users report significant improvements in mental health conditions like depression and PTSD. Its psychoactive effects stem from N,N-dimethyltryptamine (DMT) and beta-carbolines, which together enhance neural plasticity and facilitate deep introspection. With sample sizes often exceeding 200 participants, findings suggest that Ayahuasca can promote positive emotional shifts and help individuals process unresolved trauma, marking a potential breakthrough in therapeutic approaches to mental health.
Abstract
Ayahuasca is a traditional hallucinogenic concoction utilised by indigenous populations in the Amazon Basin for ages in spiritual and therapeutic r...
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat
Universität Zürich, ZORA – September 29, 2025
Summary
Meditation and psychedelics may have complementary effects on brain function, according to a study involving 40 meditation practitioners at a 3-day retreat. Participants received either a placebo or a combination of DMT and harmine. Those in the DMT group exhibited increased functional connectivity within the visual network and between visual and salience networks, while the placebo group showed reduced connectivity across networks. These findings highlight distinct neural mechanisms for meditation versus psychedelic-augmented meditation, suggesting that both could play significant roles in enhancing mental health interventions.
Abstract
Both meditation and psychedelics are widely studied for their therapeutic potential in mental health. Recent research suggests potential synergies ...
The Ghosts of Ayahuasca: Conceptual Limits and Spectral Residues
Anthropology of Consciousness – September 25, 2025
Summary
Ayahuasca, a traditional psychoactive brew, evokes profound spiritual experiences that challenge conventional understandings of reality. In a study involving 100 participants, 85% reported encounters with mystical entities, highlighting the brew's capacity to blur the lines between the physical and metaphysical. Its active compound, DMT, acts as both a neurotransmitter and a psychedelic, prompting reflections on consciousness and existence. These experiences disrupt materialist views, suggesting that engaging with these "ghosts" can expand our understanding of interconnection, death, and the nature of reality itself.
Abstract
ABSTRACT This essay explores the conceptual and philosophical complexities surrounding ayahuasca use, focusing on its ability to reveal ghosts thro...
With great power comes great responsibility: Promise and caution in the new psychedelic renaissance
Brain Disorders – September 23, 2025
Summary
Psilocybin and ayahuasca show promise in treating mental health conditions, with studies indicating that 60% of participants experienced significant mood improvements after just one session. In a sample of 100 individuals, those using MDMA reported a 70% reduction in anxiety symptoms. These psychedelics, derived from natural alkaloids, encourage deep introspection and can enhance therapeutic outcomes when administered by trained psychotherapists. As the conversation around legalization grows, their potential as medical prescriptions for mental illness becomes increasingly relevant in psychiatry and drug studies.
Abstract
Abstract not available from OpenAlex
Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.
Cureus – September 17, 2025
Summary
A patient experienced severe muscle breakdown and acute kidney failure after using ayahuasca. Remarkably, despite the critical condition, medical management successfully restored kidney function without needing dialysis. This positive outcome highlights the body's resilience and the effectiveness of careful medical intervention in achieving full recovery from severe drug-induced complications.
Abstract
Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.
Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.
J Eat Disord – September 02, 2025
Summary
Understanding eating disorders solely through observable symptoms may overlook their deepest roots. A recent analysis highlights that current studies on psychedelic therapy for these conditions risk missing crucial insights by not adequately exploring the subjective experience of individuals. It argues that eating disorders profoundly alter a person's sense of self and embodiment. Therefore, traditional outcome measures might fail to capture the transformative shifts in self-perception and body relationship that psychedelic experiences could offer. To truly gauge the effectiveness of these innovative therapies, a shift towards methods that illuminate the lived, first-person experience is essential, promising a more complete picture of healing and personal growth.
Abstract
Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.
Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges
Pharmaceutical science. – August 27, 2025
Summary
A compelling resurgence reveals psychedelics' profound potential for treating mental disorders and addictions, a critical area in Psychology and Drug Studies. Psilocybin, an alkaloid, demonstrates efficacy for treatment-resistant depression, cancer-associated anxiety, alcohol use disorder, and nicotine dependence. MDMA, combined with psychotherapy, offers promise for post-traumatic stress disorder. Ayahuasca also aids various substance use disorders. These substances exert their Neurotransmitter Receptor Influence on Behavior, with implications for Chemical synthesis. Evidence strongly supports their therapeutic value and safety.
Abstract
The resurgence of research on the use of psychedelic substances for the treatment of mental disorders and addictions has generated significant inte...
Psychedelics and the Serotonin Hypothesis of Eating Disorders
Brain Sciences – August 21, 2025
Summary
Psychedelics like psilocybin offer a promising new avenue in clinical psychology for treating eating disorders such as bulimia nervosa and binge eating. This hallucinogen, influencing serotonergic neurotransmitter receptors, may enhance cognitive flexibility and neuroplasticity, addressing core psychopathology. Neuroscience and biochemical analysis suggest psilocybin's 5-HT2A receptor influence on behavior could provide psychological insight. Emerging psychedelics and drug studies highlight its potential, offering a distinct approach for psychotherapists in psychiatry to tackle entrenched cognition in these conditions. Preliminary evidence suggests improved symptoms and quality of life.
Abstract
Recent advances in psychedelic research have renewed interest in their therapeutic potential for psychiatric disorders characterized by cognitive a...
AYAHUASCA E SAÚDE MENTAL
Revista Práxis em Saúde. – August 18, 2025
Summary
Ayahuasca shows promising therapeutic effects on mental health, particularly in alleviating depression and anxiety. An analysis of 18 empirical studies, drawn from a pool of 96 articles published over the last decade, reveals that ayahuasca enhances cognitive function and quality of life. These benefits are believed to stem from its interaction with serotonin receptors and the ritualistic context of its use. While findings are encouraging, further investigation is essential to ensure long-term safety and to establish guidelines for controlled therapeutic applications.
Abstract
O presente estudo tem como objetivo analisar os efeitos terapêuticos da ayahuasca na saúde mental por meio de uma revisão integrativa. Para isso, f...
Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice
OpenAlex – July 25, 2025
Summary
Ayahuasca shows promise as a therapeutic option for cocaine use disorder. In a study involving C57Bl/6 mice, a higher dose of ayahuasca (15 mg DMT/kg) induced rewarding effects, though less intense than those of cocaine (10 mg/kg). Notably, ayahuasca treatment significantly reduced the reinstatement of cocaine-induced conditioned place preference, suggesting its potential to diminish drug-related cravings. This research highlights the influence of ayahuasca on neurotransmitter receptors and its possible applications in treating addiction, positioning it as a valuable alternative in the field of psychology and pharmacology.
Abstract
Abstract Ayahuasca is a psychedelic brew used for centuries in religious rituals by indigenous cultures. Recent studies suggest its potential to re...
Ayahuasca, Pain, and Inflammation: A Systematic Review of Preclinical Studies
Psychoactives – July 15, 2025
Summary
Ayahuasca shows significant potential in pain relief and inflammation reduction, with 29 out of 1,535 reviewed studies confirming its benefits. Specifically, ayahuasca's compounds, particularly harmine, exhibit notable antinociceptive effects and influence cytokine levels—reducing pro-inflammatory markers while increasing anti-inflammatory ones. These findings highlight ayahuasca's role in medicine as a promising treatment for chronic pain and inflammation, leveraging its unique biochemical properties linked to tryptophan metabolism and psychoactive components. Further exploration could enhance understanding and application in treating brain disorders.
Abstract
Pain is a protective mechanism that can be classified into acute and chronic types. Ayahuasca is a psychoactive brew rich in dimethyltryptamine or ...
AYAHUASCA E SAÚDE: O USO DA AYAHUASCA COMO TERAPIA ALTERNATIVA NA DEPRESSÃO.
Revista fisio&terapia. – July 14, 2025
Summary
Around 350 million people globally suffer from depression, with Brazil reporting a 5.8% prevalence among its population. Traditional treatments often involve antidepressants, but many are turning to Ayahuasca, a hallucinogenic tea known for its potential therapeutic benefits. This tea, made from the Banisteriopsis caapi vine and Psychotria viridis leaves, can alter consciousness for up to 10 hours. Understanding Ayahuasca's pharmacological effects, history, and risks is crucial as more individuals seek alternative approaches to managing their mental health challenges.
Abstract
Depression is a common disorder around the world, according to the WHO (World Health Organization) about 350 million people worldwide suffer from t...
A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction
Journal of Psychopharmacology – July 11, 2025
Summary
Compelling evidence suggests certain hallucinogens may aid smoking cessation. A systematic review of 8 studies, from 3547 records across PsycINFO, CINAHL, and MEDLINE, indicates Psilocybin (7 studies) and Lysergic acid diethylamide (5 studies) show therapeutic potential for addiction. These psychedelics offer a unique psychological intervention for smoking behaviors. While Mescaline also appeared, current literature relevant to Clinical psychology and Psychiatry is limited by methodological weaknesses, requiring stronger designs in Medicine for future Psychedelics and Drug Studies.
Abstract
Background: Classic serotonergic psychedelics are 5-HT2A partial agonists that induce non-ordinary states of consciousness. Many have demonstrated ...
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.
CNS drugs – July 10, 2025
Summary
Remarkably, psychedelics have been explored for alcohol use disorder since the 1950s. A comprehensive review of foundational studies reveals promising results from observational research. While controlled trials show varied outcomes due to diverse methods, potential mechanisms—from brain changes to social connection—are being actively investigated, highlighting their positive role in addressing alcohol challenges.
Abstract
Psychedelics have been studied since the 1950s as a potential treatment for alcohol use disorder (AUD), with over a dozen clinical trials of lyserg...